Form 4: TriSalus Director Gary Gordon Buys TLSI Stock

TriSalus Life Sciences Director Gary B. Gordon acquired 9,756 shares of common stock at $4.10 per share in a pre-planned transaction.

Summary

• Gary B. Gordon, a Director of TriSalus Life Sciences, Inc. (TLSI), acquired 9,756 shares of the company's common stock.
• The transaction occurred on February 23, 2026, at a price of $4.10 per share.
• This purchase was made directly and is reported as a beneficial ownership of 9,756 shares following the transaction.
• The transaction was executed pursuant to a Rule 10b5-1 pre-planned contract, instruction, or written plan for the purchase of equity securities.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development. Insider buying, especially by a director, typically indicates confidence in the company's future performance and valuation, which can be a reassuring signal for investors.

Positives

• A Director's purchase of company stock signals confidence in the company's future prospects and valuation.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-meditated investment decision rather than a reaction to immediate market conditions.

Future Outlook

This filing does not contain forward-looking statements or guidance, as it reports a specific insider transaction.

Industry Context

StockSavvy.ai notes that insider buying, particularly by a director, is often interpreted by the market as a positive signal, suggesting that those closest to the company believe its shares are undervalued or expect future positive developments. This action by a TriSalus Life Sciences director could be seen as a vote of confidence in the company's strategic direction and operational execution within the life sciences sector.

Related Party Transactions

• Director Gary B. Gordon's acquisition of 9,756 shares of TriSalus Life Sciences common stock is a related party transaction.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management's belief in the company's value and future prospects, potentially boosting investor confidence.
• Employees might interpret this as a sign of stability and positive outlook from leadership.

Key Dates

Recommendation

A director's decision to purchase company stock, particularly through a pre-planned Rule 10b5-1 transaction, suggests a strong belief in the company's long-term value and future performance. This insider buying can be a compelling signal for investors, indicating that those with the most intimate knowledge of the company see an attractive investment opportunity. While not a sole determinant, it adds a layer of confidence to a potential investment thesis.

Keywords

TriSalus Life Sciences, TLSI, Insider Trading, Form 4, Stock Purchase, Director, Gary B. Gordon, Common Stock, Rule 10b5-1